| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 18 | 2015 | 660 | 0.910 |
Why?
|
| Cardiovascular Diseases | 29 | 2016 | 1970 | 0.860 |
Why?
|
| Metabolic Syndrome | 13 | 2017 | 343 | 0.730 |
Why?
|
| Coronary Disease | 15 | 2010 | 678 | 0.720 |
Why?
|
| Risk Factors | 65 | 2021 | 10314 | 0.540 |
Why?
|
| Blood Pressure | 18 | 2016 | 1375 | 0.530 |
Why?
|
| Arginine | 7 | 2014 | 336 | 0.510 |
Why?
|
| Hypertension | 18 | 2015 | 1329 | 0.500 |
Why?
|
| Longitudinal Studies | 23 | 2021 | 1324 | 0.470 |
Why?
|
| Multivariate Analysis | 17 | 2017 | 1438 | 0.460 |
Why?
|
| Massachusetts | 20 | 2017 | 125 | 0.460 |
Why?
|
| Insulin Resistance | 12 | 2014 | 641 | 0.450 |
Why?
|
| Middle Aged | 85 | 2017 | 26920 | 0.450 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 197 | 0.430 |
Why?
|
| Incidence | 33 | 2017 | 3146 | 0.400 |
Why?
|
| Biomarkers | 21 | 2017 | 3091 | 0.400 |
Why?
|
| Adipokines | 3 | 2017 | 59 | 0.390 |
Why?
|
| Aged | 65 | 2017 | 19870 | 0.390 |
Why?
|
| Body Mass Index | 20 | 2017 | 1565 | 0.380 |
Why?
|
| Models, Statistical | 4 | 2014 | 471 | 0.380 |
Why?
|
| Proportional Hazards Models | 22 | 2017 | 1360 | 0.360 |
Why?
|
| Biomedical Research | 1 | 2016 | 519 | 0.350 |
Why?
|
| Male | 98 | 2017 | 61501 | 0.350 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2011 | 1271 | 0.340 |
Why?
|
| Adiponectin | 6 | 2017 | 114 | 0.340 |
Why?
|
| Cohort Studies | 30 | 2017 | 4811 | 0.330 |
Why?
|
| Obesity | 16 | 2017 | 2248 | 0.330 |
Why?
|
| Aging | 6 | 2014 | 1181 | 0.330 |
Why?
|
| Stroke | 8 | 2017 | 989 | 0.330 |
Why?
|
| Female | 97 | 2021 | 66781 | 0.320 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2014 | 88 | 0.300 |
Why?
|
| Risk Assessment | 11 | 2015 | 3465 | 0.290 |
Why?
|
| Heart Failure | 11 | 2016 | 2298 | 0.280 |
Why?
|
| Ventricular Remodeling | 5 | 2014 | 184 | 0.270 |
Why?
|
| Cognition Disorders | 6 | 2007 | 550 | 0.260 |
Why?
|
| Adult | 50 | 2021 | 29611 | 0.260 |
Why?
|
| Humans | 105 | 2021 | 125128 | 0.260 |
Why?
|
| Follow-Up Studies | 24 | 2017 | 5176 | 0.250 |
Why?
|
| Cross-Sectional Studies | 22 | 2017 | 3423 | 0.240 |
Why?
|
| Alcohol Drinking | 3 | 2021 | 346 | 0.240 |
Why?
|
| Prospective Studies | 26 | 2021 | 6150 | 0.230 |
Why?
|
| Predictive Value of Tests | 6 | 2017 | 2173 | 0.230 |
Why?
|
| Primary Health Care | 2 | 2001 | 770 | 0.220 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2015 | 370 | 0.220 |
Why?
|
| Biometry | 1 | 2004 | 136 | 0.210 |
Why?
|
| Homocysteine | 5 | 2011 | 123 | 0.210 |
Why?
|
| Leptin | 4 | 2017 | 214 | 0.200 |
Why?
|
| Gonadotropins | 2 | 2013 | 31 | 0.200 |
Why?
|
| Sex Factors | 14 | 2016 | 1287 | 0.200 |
Why?
|
| Resistin | 3 | 2011 | 34 | 0.190 |
Why?
|
| Carbonated Beverages | 2 | 2014 | 11 | 0.190 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 19 | 0.190 |
Why?
|
| Magnesium | 2 | 2012 | 123 | 0.180 |
Why?
|
| Hospitals, Municipal | 1 | 2001 | 2 | 0.180 |
Why?
|
| Electrocardiography | 6 | 2015 | 978 | 0.180 |
Why?
|
| Stillbirth | 1 | 2021 | 79 | 0.180 |
Why?
|
| Aged, 80 and over | 20 | 2015 | 6597 | 0.180 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2001 | 74 | 0.170 |
Why?
|
| Retinol-Binding Proteins, Plasma | 3 | 2017 | 15 | 0.170 |
Why?
|
| alpha-2-HS-Glycoprotein | 3 | 2017 | 7 | 0.170 |
Why?
|
| Pregnant Women | 1 | 2021 | 143 | 0.170 |
Why?
|
| Diabetes Mellitus | 8 | 2017 | 873 | 0.170 |
Why?
|
| Linear Models | 9 | 2015 | 683 | 0.170 |
Why?
|
| Echocardiography | 5 | 2014 | 1056 | 0.170 |
Why?
|
| Violence | 1 | 2001 | 115 | 0.170 |
Why?
|
| Fatty Acid-Binding Proteins | 3 | 2017 | 30 | 0.170 |
Why?
|
| Models, Biological | 2 | 2007 | 1460 | 0.170 |
Why?
|
| Cholesterol, HDL | 7 | 2011 | 358 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2021 | 228 | 0.150 |
Why?
|
| Vascular Stiffness | 2 | 2016 | 74 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 412 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2012 | 341 | 0.140 |
Why?
|
| Child of Impaired Parents | 1 | 2017 | 15 | 0.140 |
Why?
|
| C-Reactive Protein | 7 | 2014 | 432 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2015 | 109 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2009 | 684 | 0.140 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 1689 | 0.140 |
Why?
|
| Mortality | 3 | 2009 | 238 | 0.130 |
Why?
|
| Atrial Flutter | 2 | 2015 | 32 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2000 | 474 | 0.130 |
Why?
|
| Heart Ventricles | 4 | 2009 | 772 | 0.130 |
Why?
|
| Physician-Patient Relations | 1 | 2000 | 423 | 0.130 |
Why?
|
| Fasting | 3 | 2014 | 294 | 0.130 |
Why?
|
| Transaminases | 2 | 2014 | 32 | 0.130 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2016 | 16 | 0.130 |
Why?
|
| Antihypertensive Agents | 3 | 2015 | 414 | 0.130 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2016 | 21 | 0.130 |
Why?
|
| Endothelium, Vascular | 2 | 2011 | 527 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 233 | 0.120 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 152 | 0.120 |
Why?
|
| Chromatography, Liquid | 3 | 2011 | 196 | 0.120 |
Why?
|
| Diabetic Angiopathies | 2 | 2007 | 65 | 0.120 |
Why?
|
| Troponin I | 1 | 2016 | 106 | 0.120 |
Why?
|
| Age Factors | 8 | 2014 | 2823 | 0.120 |
Why?
|
| Blood Flow Velocity | 3 | 2012 | 458 | 0.120 |
Why?
|
| Atrial Remodeling | 1 | 2014 | 11 | 0.120 |
Why?
|
| Sex Distribution | 7 | 2012 | 308 | 0.110 |
Why?
|
| Logistic Models | 6 | 2017 | 1809 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2011 | 233 | 0.110 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 29 | 0.110 |
Why?
|
| Receptor, TIE-2 | 2 | 2012 | 12 | 0.110 |
Why?
|
| Angiopoietin-2 | 2 | 2012 | 13 | 0.110 |
Why?
|
| United States | 16 | 2015 | 10891 | 0.110 |
Why?
|
| Myocardial Infarction | 4 | 2015 | 1050 | 0.110 |
Why?
|
| Age Distribution | 6 | 2014 | 419 | 0.110 |
Why?
|
| Prognosis | 9 | 2015 | 4644 | 0.110 |
Why?
|
| Heart Murmurs | 2 | 2013 | 15 | 0.110 |
Why?
|
| Heart Atria | 3 | 2010 | 316 | 0.100 |
Why?
|
| Neuropsychological Tests | 6 | 2007 | 919 | 0.100 |
Why?
|
| Magnesium Deficiency | 1 | 2012 | 11 | 0.100 |
Why?
|
| Time Factors | 10 | 2015 | 6329 | 0.100 |
Why?
|
| Caffeine | 2 | 2010 | 71 | 0.100 |
Why?
|
| Insulin | 3 | 2014 | 1203 | 0.100 |
Why?
|
| Models, Cardiovascular | 1 | 2014 | 185 | 0.100 |
Why?
|
| Blood Glucose | 3 | 2016 | 1131 | 0.100 |
Why?
|
| Smoking | 8 | 2016 | 1051 | 0.100 |
Why?
|
| Carotid Artery Diseases | 2 | 2015 | 148 | 0.100 |
Why?
|
| Homes for the Aged | 1 | 1992 | 24 | 0.100 |
Why?
|
| Nitric Oxide Synthase | 2 | 2011 | 187 | 0.100 |
Why?
|
| Schizophrenia | 2 | 2005 | 311 | 0.100 |
Why?
|
| Stress, Psychological | 3 | 2007 | 559 | 0.100 |
Why?
|
| Educational Status | 4 | 2006 | 275 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2012 | 50 | 0.100 |
Why?
|
| Cause of Death | 6 | 2013 | 476 | 0.100 |
Why?
|
| Prevalence | 7 | 2021 | 2458 | 0.100 |
Why?
|
| Nursing Homes | 1 | 1992 | 93 | 0.090 |
Why?
|
| Menopause | 1 | 2012 | 77 | 0.090 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2014 | 312 | 0.090 |
Why?
|
| Overweight | 3 | 2013 | 364 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2011 | 250 | 0.090 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 129 | 0.090 |
Why?
|
| Triglycerides | 3 | 2009 | 575 | 0.090 |
Why?
|
| Brachial Artery | 1 | 2011 | 39 | 0.090 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2010 | 65 | 0.090 |
Why?
|
| Dietary Fiber | 1 | 2010 | 75 | 0.090 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 32 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 1992 | 363 | 0.080 |
Why?
|
| Vasodilation | 1 | 2011 | 192 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 14 | 0.080 |
Why?
|
| Quality Control | 1 | 2010 | 121 | 0.080 |
Why?
|
| Adult Children | 1 | 2009 | 4 | 0.080 |
Why?
|
| Tunica Media | 1 | 2009 | 14 | 0.080 |
Why?
|
| Algorithms | 3 | 2013 | 1629 | 0.080 |
Why?
|
| Tunica Intima | 1 | 2009 | 59 | 0.080 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2009 | 29 | 0.080 |
Why?
|
| Substance-Related Disorders | 2 | 2006 | 460 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2010 | 294 | 0.080 |
Why?
|
| Longevity | 1 | 2010 | 135 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 41 | 0.080 |
Why?
|
| Inflammation | 5 | 2010 | 1446 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 2637 | 0.070 |
Why?
|
| Reference Standards | 1 | 2009 | 236 | 0.070 |
Why?
|
| HIV Infections | 1 | 2000 | 1899 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2010 | 201 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2011 | 472 | 0.070 |
Why?
|
| Regression Analysis | 4 | 2016 | 780 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2012 | 853 | 0.070 |
Why?
|
| Risk | 5 | 2011 | 756 | 0.070 |
Why?
|
| Odds Ratio | 4 | 2017 | 1259 | 0.070 |
Why?
|
| Lipoproteins, HDL | 1 | 2008 | 100 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 1056 | 0.070 |
Why?
|
| Marriage | 1 | 2007 | 28 | 0.070 |
Why?
|
| Marital Status | 1 | 2007 | 33 | 0.070 |
Why?
|
| Apolipoproteins | 1 | 2007 | 70 | 0.070 |
Why?
|
| Receptors, Leptin | 2 | 2017 | 40 | 0.070 |
Why?
|
| Genotype | 2 | 2014 | 2565 | 0.070 |
Why?
|
| Hyperhomocysteinemia | 2 | 2004 | 38 | 0.070 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 268 | 0.070 |
Why?
|
| Phosphorus | 1 | 2007 | 56 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2010 | 389 | 0.070 |
Why?
|
| Infant, Low Birth Weight | 1 | 2007 | 167 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2009 | 465 | 0.070 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2007 | 74 | 0.060 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2006 | 39 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2010 | 495 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 533 | 0.060 |
Why?
|
| Reference Values | 3 | 2011 | 718 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2007 | 252 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2007 | 203 | 0.060 |
Why?
|
| Liver | 1 | 2012 | 1748 | 0.060 |
Why?
|
| Cholesterol | 2 | 2005 | 541 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 129 | 0.060 |
Why?
|
| Chromosome Disorders | 1 | 2007 | 311 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 222 | 0.060 |
Why?
|
| Pedigree | 3 | 2017 | 1606 | 0.060 |
Why?
|
| Socioeconomic Factors | 3 | 2005 | 871 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2011 | 1502 | 0.060 |
Why?
|
| Kidney | 1 | 2011 | 1368 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2007 | 255 | 0.060 |
Why?
|
| Hyperuricemia | 1 | 2004 | 38 | 0.060 |
Why?
|
| Uric Acid | 1 | 2004 | 95 | 0.060 |
Why?
|
| Hostility | 1 | 2004 | 21 | 0.060 |
Why?
|
| Ultrasonography | 4 | 2011 | 941 | 0.060 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 228 | 0.060 |
Why?
|
| Anger | 1 | 2004 | 30 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1120 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 880 | 0.050 |
Why?
|
| Social Support | 1 | 2006 | 345 | 0.050 |
Why?
|
| Occupational Diseases | 1 | 2004 | 74 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3157 | 0.050 |
Why?
|
| Premature Birth | 1 | 2007 | 387 | 0.050 |
Why?
|
| Confidence Intervals | 3 | 2012 | 286 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2006 | 259 | 0.050 |
Why?
|
| Creatinine | 2 | 2016 | 391 | 0.050 |
Why?
|
| Calcium | 1 | 2007 | 1102 | 0.050 |
Why?
|
| Adiposity | 2 | 2014 | 190 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 371 | 0.050 |
Why?
|
| South Dakota | 1 | 2021 | 2 | 0.050 |
Why?
|
| North Dakota | 1 | 2021 | 6 | 0.050 |
Why?
|
| Albuminuria | 2 | 2015 | 103 | 0.050 |
Why?
|
| South Africa | 1 | 2021 | 99 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 589 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2012 | 54 | 0.040 |
Why?
|
| Boston | 1 | 2001 | 109 | 0.040 |
Why?
|
| Survival Rate | 3 | 2014 | 2062 | 0.040 |
Why?
|
| Rhode Island | 1 | 2000 | 6 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3073 | 0.040 |
Why?
|
| Mathematical Computing | 1 | 2000 | 9 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2001 | 105 | 0.040 |
Why?
|
| Firearms | 1 | 2001 | 42 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2000 | 97 | 0.040 |
Why?
|
| Interview, Psychological | 1 | 2000 | 97 | 0.040 |
Why?
|
| Surveys and Questionnaires | 3 | 2010 | 3724 | 0.040 |
Why?
|
| Urban Population | 1 | 2001 | 227 | 0.040 |
Why?
|
| Comorbidity | 4 | 2005 | 1534 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2010 | 105 | 0.040 |
Why?
|
| Cholesterol, LDL | 3 | 2007 | 571 | 0.040 |
Why?
|
| England | 2 | 2011 | 59 | 0.040 |
Why?
|
| Interleukin-6 | 3 | 2006 | 420 | 0.040 |
Why?
|
| Organ Size | 2 | 2010 | 436 | 0.040 |
Why?
|
| Population Surveillance | 3 | 2008 | 389 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 592 | 0.040 |
Why?
|
| Adolescent | 6 | 2011 | 19361 | 0.040 |
Why?
|
| Health Behavior | 1 | 2001 | 385 | 0.040 |
Why?
|
| Heredity | 1 | 2017 | 15 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 370 | 0.030 |
Why?
|
| Cytokines | 1 | 2003 | 1289 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2012 | 313 | 0.030 |
Why?
|
| Pregnancy | 3 | 2021 | 7208 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2016 | 89 | 0.030 |
Why?
|
| Pulse Wave Analysis | 1 | 2015 | 47 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2006 | 141 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 82 | 0.030 |
Why?
|
| Glucose Intolerance | 2 | 2007 | 78 | 0.030 |
Why?
|
| Chemokine CCL2 | 2 | 2006 | 122 | 0.030 |
Why?
|
| Non-Nutritive Sweeteners | 1 | 2014 | 1 | 0.030 |
Why?
|
| Nutritive Sweeteners | 1 | 2014 | 2 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2014 | 23 | 0.030 |
Why?
|
| Young Adult | 3 | 2015 | 9049 | 0.030 |
Why?
|
| Propensity Score | 1 | 2015 | 216 | 0.030 |
Why?
|
| Mediator Complex | 1 | 2014 | 51 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2015 | 16348 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 2014 | 108 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 295 | 0.030 |
Why?
|
| Demography | 2 | 2005 | 239 | 0.030 |
Why?
|
| Lipids | 2 | 2007 | 523 | 0.030 |
Why?
|
| Breath Tests | 1 | 2014 | 178 | 0.030 |
Why?
|
| Heart Rate | 1 | 2016 | 592 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2000 | 968 | 0.030 |
Why?
|
| Life Style | 2 | 2007 | 414 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 398 | 0.030 |
Why?
|
| Motor Activity | 2 | 2007 | 520 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2014 | 339 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 798 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 767 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 733 | 0.020 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2011 | 5 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 2011 | 43 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2015 | 292 | 0.020 |
Why?
|
| Potassium | 1 | 2012 | 283 | 0.020 |
Why?
|
| Disease Progression | 2 | 2010 | 2067 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1303 | 0.020 |
Why?
|
| Self Report | 1 | 2014 | 517 | 0.020 |
Why?
|
| Patient Admission | 1 | 1992 | 184 | 0.020 |
Why?
|
| Seafood | 1 | 2010 | 7 | 0.020 |
Why?
|
| Community Health Services | 1 | 2011 | 89 | 0.020 |
Why?
|
| Data Collection | 2 | 2005 | 375 | 0.020 |
Why?
|
| Colorimetry | 1 | 2010 | 16 | 0.020 |
Why?
|
| Fishes | 1 | 2010 | 38 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2010 | 98 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 989 | 0.020 |
Why?
|
| Systole | 1 | 2010 | 200 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 210 | 0.020 |
Why?
|
| Phenotype | 2 | 2011 | 4262 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 128 | 0.020 |
Why?
|
| Europe | 1 | 2010 | 354 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1897 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 297 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2009 | 68 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 351 | 0.020 |
Why?
|
| Carotid Artery, Common | 1 | 2009 | 73 | 0.020 |
Why?
|
| Community Participation | 1 | 2009 | 44 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2010 | 453 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 507 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2010 | 278 | 0.020 |
Why?
|
| Sucrose | 1 | 2007 | 39 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2007 | 81 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 114 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2007 | 33 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 2007 | 134 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2010 | 234 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2008 | 724 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 490 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2007 | 114 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2007 | 208 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2913 | 0.020 |
Why?
|
| Hypertriglyceridemia | 1 | 2007 | 104 | 0.020 |
Why?
|
| Inactivation, Metabolic | 1 | 2006 | 31 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 46 | 0.020 |
Why?
|
| Occupations | 1 | 2005 | 22 | 0.020 |
Why?
|
| Pyridoxine | 1 | 2005 | 14 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2007 | 148 | 0.020 |
Why?
|
| Particle Size | 1 | 2005 | 124 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2015 | 12391 | 0.020 |
Why?
|
| P-Selectin | 1 | 2006 | 80 | 0.020 |
Why?
|
| Hemostasis | 1 | 2006 | 70 | 0.020 |
Why?
|
| Methadone | 1 | 2006 | 126 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2005 | 59 | 0.020 |
Why?
|
| ROC Curve | 1 | 2007 | 569 | 0.020 |
Why?
|
| Narcotic Antagonists | 1 | 2006 | 109 | 0.010 |
Why?
|
| Waist-Hip Ratio | 1 | 2005 | 56 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 320 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2820 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2005 | 109 | 0.010 |
Why?
|
| Anthropometry | 1 | 2005 | 197 | 0.010 |
Why?
|
| Social Class | 1 | 2006 | 190 | 0.010 |
Why?
|
| Energy Intake | 1 | 2007 | 494 | 0.010 |
Why?
|
| Emotions | 1 | 2007 | 356 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2005 | 294 | 0.010 |
Why?
|
| Type A Personality | 1 | 2004 | 2 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 2004 | 17 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 197 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 2057 | 0.010 |
Why?
|
| Language | 1 | 2005 | 195 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 2004 | 81 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2010 | 1004 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2004 | 168 | 0.010 |
Why?
|
| Morbidity | 1 | 2004 | 249 | 0.010 |
Why?
|
| Folic Acid | 1 | 2005 | 294 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 2005 | 320 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2885 | 0.010 |
Why?
|
| Homeostasis | 1 | 2007 | 703 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 2002 | 58 | 0.010 |
Why?
|
| Recurrence | 1 | 2006 | 1420 | 0.010 |
Why?
|
| Parents | 1 | 2009 | 1025 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 326 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2007 | 702 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1100 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2004 | 448 | 0.010 |
Why?
|
| Diet | 1 | 2007 | 1140 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 230 | 0.010 |
Why?
|
| Anxiety | 1 | 2005 | 957 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 4534 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 3056 | 0.010 |
Why?
|
| Software | 1 | 2000 | 684 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2007 | 8232 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 34235 | 0.010 |
Why?
|
| Neoplasms | 1 | 2004 | 2790 | 0.000 |
Why?
|